ES2162560A1 - Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia. - Google Patents

Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.

Info

Publication number
ES2162560A1
ES2162560A1 ES009901286A ES9901286A ES2162560A1 ES 2162560 A1 ES2162560 A1 ES 2162560A1 ES 009901286 A ES009901286 A ES 009901286A ES 9901286 A ES9901286 A ES 9901286A ES 2162560 A1 ES2162560 A1 ES 2162560A1
Authority
ES
Spain
Prior art keywords
srsi
paroxetine
fluoxetine
refrain
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009901286A
Other languages
English (en)
Other versions
ES2162560B1 (es
Inventor
Rodriguez Concepcion Pena
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES009901286A priority Critical patent/ES2162560B1/es
Priority to PCT/ES2000/000219 priority patent/WO2001000202A1/es
Publication of ES2162560A1 publication Critical patent/ES2162560A1/es
Application granted granted Critical
Publication of ES2162560B1 publication Critical patent/ES2162560B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Los inhibidores selectivos de la recaptación de serotonina (ISRS), como la fluoxetina, paroxetina, fluvoxamina, sertralina, etc. poseen la capacidad de disminuir las obsesiones; dado que hemos comprobado que las toxicomanías y otras dependencias reúnen características que guardan una gran semejanza con las obsesiones, consideramos que dichas sustancias pueden ser utilizadas en una forma nueva: para aumentar la capacidad de las personas de abstenerse de tóxicos o actividades que les hayan provocado una dependencia, aumentando así el tiempo de abstinencia conseguido en los tratamientos actuales y evitando las recaídas.
ES009901286A 1999-06-25 1999-06-25 Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia. Expired - Lifetime ES2162560B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES009901286A ES2162560B1 (es) 1999-06-25 1999-06-25 Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
PCT/ES2000/000219 WO2001000202A1 (es) 1999-06-25 2000-06-22 Utilizacion de fluoxetina, paroxetina y otros isrs como medicamentos para aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009901286A ES2162560B1 (es) 1999-06-25 1999-06-25 Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.

Publications (2)

Publication Number Publication Date
ES2162560A1 true ES2162560A1 (es) 2001-12-16
ES2162560B1 ES2162560B1 (es) 2002-07-16

Family

ID=8308783

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009901286A Expired - Lifetime ES2162560B1 (es) 1999-06-25 1999-06-25 Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.

Country Status (2)

Country Link
ES (1) ES2162560B1 (es)
WO (1) WO2001000202A1 (es)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250572A (en) * 1990-03-29 1993-10-05 Eli Lilly And Company (R)-norfluoxetine in method for occupying serotonin IC receptors
WO1997003670A1 (en) * 1995-07-20 1997-02-06 Smithkline Beecham P.L.C. Paroxetine controlled release compositions
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
WO1998031365A1 (en) * 1997-01-15 1998-07-23 Smithkline Beecham Plc Paroxetine compositions
FR2763846A1 (fr) * 1997-05-29 1998-12-04 Lilly Co Eli Pilules de fluoxetine enteriques

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250572A (en) * 1990-03-29 1993-10-05 Eli Lilly And Company (R)-norfluoxetine in method for occupying serotonin IC receptors
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
WO1997003670A1 (en) * 1995-07-20 1997-02-06 Smithkline Beecham P.L.C. Paroxetine controlled release compositions
WO1998031365A1 (en) * 1997-01-15 1998-07-23 Smithkline Beecham Plc Paroxetine compositions
FR2763846A1 (fr) * 1997-05-29 1998-12-04 Lilly Co Eli Pilules de fluoxetine enteriques

Also Published As

Publication number Publication date
ES2162560B1 (es) 2002-07-16
WO2001000202A1 (es) 2001-01-04

Similar Documents

Publication Publication Date Title
ZA200301813B (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
BG104780A (en) Inhibitors of phospholipase enzymes
HUP0201214A3 (en) Inhibitors of impdh enzyme, pharmaceutical compositions containing them and their use
HUP0200355A3 (en) 4-aminopyrrolopyrimidines as kinase inhibitors, pharmaceutical compositions containing them and their use
IL151313A0 (en) Lipase containing pharmaceutical compositions
MY133996A (en) Compounds for the treatment of ischemia
AU3652102A (en) Compounds and their uses
HUP0500574A3 (en) Acridone inhibitors of impdh enzyme, pharmaceutical compositions containing them and their use
MY122771A (en) Heterocyclically substituted benzimidazoles, their preparation and use thereof
ZA200108082B (en) Pharmaceutical compositions comprising dipeptidy peptidase IV inhibitors for the promotion of growth.
MXPA02005602A (es) Compuestos de urea que tienen actividad antagonista para el receptor muscarinico.
BR9911724A (pt) Ciclosporina que tem um perfil de atividade melhorado
HUP0103283A3 (en) Pyrazinone protease inhibitors, pharmaceutical compositions containing them and use of the compounds
BR0110961A (pt) Derivados de triazol
AU2002220715A1 (en) Indolsulfonyl compounds useful in the treatment of cns disorders
IT1299317B1 (it) Pacchetto di sigarette.
MY129668A (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
MXPA03010158A (es) Sulfonamidas.
HUP0103431A3 (en) Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent
EA200000165A1 (ru) Разветвленные алкоксизамещенные-2-аминопиридины в качестве ингибиторов nos
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
EP1246619A4 (en) UROTENSIN II RECEPTOR ANTAGONISTS
ES2193105T3 (es) Caramelos duros de estabilidad mejorada al almacenaje.
ES2162560A1 (es) Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
FR2873377B1 (fr) Derives d'azasucre, inhibiteurs d'heparanases, leur procede de preparation, les compositions en contenant et leur utilisation

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20011216

Kind code of ref document: A1

Effective date: 20011216

FA2A Application withdrawn

Effective date: 20031120